Combined treatment with racemic-DMSA and EDTA for lead mobilization in rats

Journal of Trace Elements in Experimental Medicine

Volumn 13, Issue 3, 2000, Pages 277-284

  Kostial, Krista ^a   Restek Samaržija, Nada ^a   Piasek, Martina ^a   Varnai, Veda Marija ^a   Blanuša, Maja ^a   Jones, Mark M ^b   Singh, Pramod K ^b,c  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b VANDERBILT UNIVERSITY   (United States)

^c Food Residue and Toxicology Lab   (United States)

Author keywords

CaNa2EDTA; Chelation therapy; Copper; DMSA stereoisomers; Iron; Lead poisoning; Zinc

Indexed keywords

CHELATING AGENT; COPPER; EDETIC ACID; IRON; LEAD; SUCCIMER; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CHELATION THERAPY; FEMALE; FEMUR; KIDNEY; LEAD POISONING; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOISOMERISM; TISSUE LEVEL; URINE LEVEL; ZINC URINE LEVEL;

EID: 0033931532     PISSN: 0896548X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-670X(2000)13:3<277::AID-JTRA5>3.0.CO;2-2     Document Type: Article

References (20)

1. Goyer RA, Cherian MG, Jones MM, Reigart JR. Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals. Environ Health Perspect 1995;103:1048-1052.
2. Besunder JB, Super DM, Anderson RL. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning. J Pediatr 1997;130:966-971.
3. Lee BK, Schwartz BS, Stewart W, Ahn KD. Provocative chelation with DMSA and EDTA, evidence for differential access to lead storage sites. Occup Environ Med 1995;52:13-19.
4. Chisolm JJ Jr. BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children. J Toxicol Clin Toxicol 1992;30:493-504.
5. Liebelt EL, Shannon M, Graef JW. Efficacy of oral meso-2,3-dimercaptosuccinic acid therapy for low-level childhood plumbism. J Pediatr 1994;124:313-317.
6. Cory-Slechta DA, Weiss B, Cox C. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tretraacetate chelation therapy. J Pharmacol Exp Ther 1987;243:804-813.
7. Cory-Slechta DA. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy. J Phamacol Exp Ther 1988;246:84-91.
8. Flora SJS, Seth PK, Prakash AO, Mathur R. Therapeutic efficacy of combined meso-2,3-dimercaptosuccinic acid and calcium disodium edetate treatment during acute lead intoxication in rats. Hum Exp Toxicol 1995;14:410-413.
9. Flora SJS, Bhattacharya R, Vijayaraghavan R. Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats. Fundam Appl Toxicol 1995;25:233-240.
10. Jones MM, Singh PK, Kostial K, Blanuša M, Piasek M, Restek-Samaržija N. Comparative in vivo lead mobilization of meso- and rac-2,3-dimercaptosuccinic acids in albino Wistar rats. Pharmacol Toxicol 1997;80:182-186.
11. American Academy of Pediatrics Committee on Drugs. Treatment guidelines for lead exposure in children. Pediatrics 1995;96:155-160.
12. Knapka JJ, Smith KP, Judge FJ. Effect of open and closed formula rations on the performance of three strains of laboratory mice. Lab Anim Sci 1974;24:480-487.
13. Hammond PB, Jones MM, Succop PA, Singh PK, Basinger MA. Validity of femur and tibia as surrogates for total skeletal burden of lead. Toxicol Methods 1992;2:169-176.
14. Smith DR, Flegal AR. Stable isotopic tracers of lead mobilized by DMSA chelation in low lead-exposed rats. Toxicol Appl Pharmacol 1992;116:85-91.
15. World Health Organization. Inorganic lead: environmental health criteria 165. Geneva: WHO, 1995.
16. Graziano JH, Lolacono N, Moulton T, Mitchell ME, Slavkovich V, Zarate C. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. J Pediatr 1992;120:133-139.
17. Ding GS, Liang YY. Antidotal effects of dimercaptosuccinic acid. J Appl Toxicol 1991;11:7-14.
18. Fang XJ, Fernando Q. Stereoisomeric selectivity of 2,3-dimercaptosuccinic acids in chelation therapy for lead poisoning. Chem Res Toxicol 1995;8:525-536.
19. Kostial K, Restek-Samaržija N, Blanuša M, Piasek M, Jones MM, Singh PK. Combined oral treatment with racemic- and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats. Pharmacol Toxicol 1997;81:242-244.
20. Kostial K, Restek-Samaržija N, Blanuša M, Piasek M, Prester LJ, Jones MM, Singh PK. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats. J Appl Toxicol 1997;17:71-74.